DTRMWXHS ‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study

Autor: Scott F. Huntington, Stephen J. Schuster, Wei Ding, Amber B. Koehler, Danielle M. Brander, Allison C. Rosenthal, Jose F. Leis, Han W. Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S. Kearney, Timothy P. McKinlay, Min Gui, Anthony R. Mato
Rok vydání: 2023
Předmět:
Zdroj: American Journal of Hematology. 98:739-749
ISSN: 1096-8652
0361-8609
DOI: 10.1002/ajh.26888
Databáze: OpenAIRE
Externí odkaz: